Stany Zjednoczone - angielski - NLM (National Library of Medicine)

guardian drug company - bismuth subsalicylate (unii: 62tey51rr1) (bismuth cation - unii:zs9cd1i8ye) - bismuth subsalicylate 262 mg in 15 ml - upset stomach reliever and anti-diarrheal relieves: - diarrhea - heartburn - indigestion - nausea - upset stomach associated with these symptoms

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

reliable 1 laboratories llc - bismuth subsalicylate (unii: 62tey51rr1) (bismuth cation - unii:zs9cd1i8ye, salicylic acid - unii:o414pz4lpz) - bismuth subsalicylate 262 mg - anti-diarrheal / upset stomach reliever - controls diarrhea - relieves upset stomach due to overindulgence in food or drink do not use - if you have bloody or black stool - if you have an ulcer or bleeding problem drug facts continued on back of label stop use and ask a doctor if - symptoms get worse or last more than 2 days - ringing in the ears or loss of hearing occurs - diarrhea lasts more than 2 days

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

rugby laboratories inc. - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz) - bismuth subsalicylate 262 mg - anti-diarrheal / upset stomach reliever - controls diarrhea - relieves upset stomach due to overindulgence in food or drink

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

aurohealth llc - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz, bismuth cation - unii:zs9cd1i8ye) - bismuth subsalicylate 1050 mg in 30 ml - upset stomach reliever and antidiarrheal relieves - travelers’ diarrhea - diarrhea - upset stomach due to overindulgence in food and drink, including: heartburn indigestion nausea gas belching fullness - heartburn - indigestion - nausea - gas - belching - fullness - an ulcer - a bleeding problem - bloody or black stool - fever - mucus in the stool - anticoagulation (thinning the blood) - diabetes - gout - arthritis when using this product a temporary, but harmless, darkening of the stool and/or tongue may occur - symptoms get worse - ringing in the ears or loss of hearing occurs - diarrhea lasts more than 2 days if pregnant or breast feeding, ask a health professional before use.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

mwi/vet one - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz) - bismuth subsalicylate 17.4 g in 1 l - suspension anti-diarrheal liquid a palatable oral suspension for use as an aid in controlling simple diarrhea in cattle, horses, dogs and cats.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

mwi/vetone - bismuth subsalicylate (unii: 62tey51rr1) (bismuth cation - unii:zs9cd1i8ye) - bismuth subsalicylate 18 mg in 1 ml - a palatable oral suspension for use as an aid in controlling simple diarrhea in cattle, horses, dogs and cats

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

aspen veterinary - bismuth subsalicylate (unii: 62tey51rr1) (bismuth cation - unii:zs9cd1i8ye) - bismuth subsalicylate 18 mg in 1 ml - a palatable oral suspension for use as an aid in controlling simple diarrhea in cattle, horses, dogs and cats. store at controlled room temperature not above 37ºc (98.6ºf).  restricted drug. use only as directed. not for human use. take time observe label directions lot no.           exp. date

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

american animal health, inc. - bismuth subsalicylate (unii: 62tey51rr1) (bismuth subsalicylate - unii:62tey51rr1) - bismuth subsalicylate 0.0175 mg in 1 ml

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

marc glassman, inc. - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz) - bismuth subsalicylate 262 mg - antidiarrheal/antacid ■ controls diarrhea    ■ relieves heartburn, indigestion, nausea and upset stomach

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

par pharmaceutical, inc. - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth cation - unii:zs9cd1i8ye), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori has been shown to reduce the risk of duodenal ulcer recurrence. to reduce the development of drug-resistant bacteria and maintain the effectiveness of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules and other antibacterial drugs, bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules should be used to treat only indicated infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may